Chemoinformaics analysis of 24-Methylene-31-Nor-5alpha-Lanost-9(11)-3beta-Ol
| Molecular Weight | 426.729 | nRot | 5 |
| Heavy Atom Molecular Weight | 376.329 | nRig | 21 |
| Exact Molecular Weight | 426.386 | nRing | 4 |
| Solubility: LogS | -6.914 | nHRing | 0 |
| Solubility: LogP | 7.184 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 84.2417 |
| nHD | 1 | BPOL | 50.1604 |
| QED | 0.439 |
| Synth | 4.809 |
| Natural Product Likeliness | 3.488 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.785 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.771 |
| MDCK | 0.00000808 |
| BBB | 0.802 |
| PPB | 0.99496 |
| VDSS | 2.104 |
| FU | 0.0203871 |
| CYP1A2-inh | 0.042 |
| CYP1A2-sub | 0.554 |
| CYP2c19-inh | 0.061 |
| CYP2c19-sub | 0.97 |
| CYP2c9-inh | 0.099 |
| CYP2c9-sub | 0.425 |
| CYP2d6-inh | 0.057 |
| CYP2d6-sub | 0.898 |
| CYP3a4-inh | 0.284 |
| CYP3a4-sub | 0.864 |
| CL | 13.286 |
| T12 | 0.008 |
| hERG | 0.014 |
| Ames | 0.048 |
| ROA | 0.363 |
| SkinSen | 0.033 |
| Carcinogencity | 0.108 |
| EI | 0.009 |
| Respiratory | 0.667 |
| NR-Aromatase | 0.089 |
| Antiviral | No |
| Prediction | 0.73364 |